Multicancer assays leverage cfDNA methylation patterns to detect malignancy and infer tumor origin, with reported tissue-of-origin prediction approaching 87% accuracy in real-world experience. The 142 ...

Analyses of a 40% SHI sample estimated vitiligo prevalence at 0.19% in 2020 (~148,000 individuals nationally), enabling population-level quantification of psychiatric comorbidity patterns. Depressive ...

Noah Greenspan, DPT, discusses how oxygen therapy, detailed evaluation, and trial-and-error approaches may help manage long ...

CMMI’s agenda centers on productivity and value-based payment expansion, including outcomes-based reimbursement, Most-Favored ...

NSFG 2015–2019 analyses excluded surgical sterility and clinical infertility, yet >20% reported diagnosed reproductive health conditions, highlighting a sizable s ...

With the launch of such a service, questions surrounding what it is exactly and its efficacy in reducing drug prices have been a prominent discussion. Below, we answer some frequently asked questions ...

GPT-4o achieved ICC/CCC of 0.815/0.866 versus in-person SALT scoring and 0.833/0.817 versus image-based scoring, while expert ...

Orphan status in the U.S. can confer clinical-trial tax credits, user-fee exemptions, and up to seven years of post-approval market exclusivity for rare-disease programs. As a deuterated form of ...

Objective: To conduct a cost-effectiveness analysis comparing behavioral health integration (BHI) in primary care vs clinical decision support (usual care) for adult pat ...

A BTK inhibitor combined with standard R-CHOP produced rapid, PET-defined complete remission in high-risk DLBCL-type Richter syndrome with TP53 deletion. Delaying ibrutinib until cycle 2 was used as a ...

Rising national health expenditures and high administrative overhead create a compelling but not definitive business case for AI-enabled automation across billing, claims, and compliance functions.

Beyond progression-free survival, the combination of teclistamab and daratumumab hyaluronidase-fihj showed deep clinical responses, notes Ajay K. Nooka, MD, MPH. Clinical data showed that 83% of ...